Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor.

Leukemia · 2017 · PMC5629371 · PMID 28074066

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Absolute cell counts confirmed the highly significant depletion of target cell populations ( Figure 3d ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.